Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT): Margin Dip to 18.4% Challenges Recent Bullish Narratives

Corcept Therapeutics (CORT) posted average earnings growth of 5.5% annually over the past five years, with a 5.6% uptick in the most recent year. Revenue is forecast to climb sharply at 28.2% per year, far outpacing the projected 10.4% growth rate for the US market. While net profit margins have dipped to 18.4% from last year’s 21.9%, high earnings quality and robust growth expectations continue to fuel positive investor sentiment despite a premium valuation. See our full analysis for Corcept...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX): Losses Worsen While 54.9% Projected Revenue Growth Tests Bullish Narratives

ImmunityBio (IBRX) reported another unprofitable period, with losses accelerating at a 15% annual rate over the past five years and net profit margins failing to show improvement. Forecasts suggest the company will remain unprofitable for at least the next three years. However, revenue is projected to surge by 54.9% per year, far outpacing the broader US market's 10.4% average growth rate. Investors now face the challenge of weighing a robust revenue outlook against ongoing losses and high...
NYSE:AIZ
NYSE:AIZInsurance

Assurant (AIZ): Margin Compression Challenges Bullish Community Narratives Despite Fair Value Discount

Assurant (AIZ) posted a net profit margin of 5.8%, down from last year's 6.9%, while earnings have grown at an average rate of 9.7% annually over the past five years. Market forecasts suggest earnings and revenue will continue to rise at 11.9% and 4.1% per year respectively, both trailing the broader US market’s growth outlook. Shares currently trade at a P/E of 15.4x, above industry and peer averages, but the price remains below an internally estimated fair value, putting the spotlight on...
NYSE:CNX
NYSE:CNXOil and Gas

Has the Recent Jump in Gas Demand Forecasts Changed the Outlook for CNX Resources in 2025?

If you’ve ever wondered whether CNX Resources is a bargain or priced for perfection, you’re not alone. Figuring that out is where smart investing starts. Despite a tough year with the stock down 8.3% over the last 12 months, short-term performance is turning around, up 7.1% just this week. Recent news has focused on increased natural gas demand forecasts and shifting analyst sentiment, which are fueling renewed interest in energy stocks like CNX. Momentum from policy changes around domestic...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

S&P 500 Futures Dip as Debt and Yield Worries Weigh

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are drifting lower this morning as investors weigh a jump in long-term bond yields and a new record for household debt. The prospect of higher borrowing costs and elevated debt levels is spurring fresh caution across the market and putting pressure on consumer-focused stocks, as investors focus on the risk that financial strain could temper the economy’s momentum. Act now to uncover undervalued stocks based on...